These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33775260)

  • 21. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
    Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
    Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.
    Blagburn BL; Drain KL; Land TM; Kinard RG; Moore PH; Lindsay DS; Patrick DA; Boykin DW; Tidwell RR
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2877-82. PubMed ID: 9797219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.
    Gargala G; Le Goff L; Ballet JJ; Favennec L; Stachulski AV; Rossignol JF
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1315-8. PubMed ID: 20047919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
    Khaleil SR; Mira NM; Ghanem NF; M El-Mehasseb I; Helal IB; El-Shafai NM
    Int J Biol Macromol; 2023 Aug; 247():125823. PubMed ID: 37453638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of selenium on Cryptosporidium parvum infection in vitro and in vivo.
    Huang K; Yang S
    Biol Trace Elem Res; 2002; 90(1-3):261-72. PubMed ID: 12666840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
    Moustafa MA
    J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.
    Baishanbo A; Gargala G; Delaunay A; François A; Ballet JJ; Favennec L
    Infect Immun; 2005 Aug; 73(8):5252-5. PubMed ID: 16041051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feeding activated charcoal from bark containing wood vinegar liquid (nekka-rich) is effective as treatment for cryptosporidiosis in calves.
    Watarai S; Tana ; Koiwa M
    J Dairy Sci; 2008 Apr; 91(4):1458-63. PubMed ID: 18349239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
    Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
    PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Gattan HS; Wakid MH; Qahwaji RM; Altwaim S; Mahjoub HA; Alfaifi MS; Elshazly H; Al-Megrin WAI; Alshehri EA; Elshabrawy HA; El-Kady AM
    Front Vet Sci; 2024; 11():1374116. PubMed ID: 38515537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
    Costa LB; JohnBull EA; Reeves JT; Sevilleja JE; Freire RS; Hoffman PS; Lima AA; Oriá RB; Roche JK; Guerrant RL; Warren CA
    J Parasitol; 2011 Dec; 97(6):1113-20. PubMed ID: 21711105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats.
    Rehg JE
    J Parasitol; 1996 Feb; 82(1):158-62. PubMed ID: 8627487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats.
    Rasmussen KR; Arrowood MJ; Healey MC
    Antimicrob Agents Chemother; 1992 Jan; 36(1):220-2. PubMed ID: 1534212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin.
    Brasseur P; Favennec L; Leméteil D; Roussel F; Ballet JJ
    Folia Parasitol (Praha); 1994; 41(1):13-6. PubMed ID: 8050749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
    Rossignol JF; Ayoub A; Ayers MS
    J Infect Dis; 2001 Jul; 184(1):103-6. PubMed ID: 11398117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of halofuginone in immunosuppressed rats infected with Cryptosporidium parvum.
    Rehg JE
    J Antimicrob Chemother; 1995 Mar; 35(3):391-7. PubMed ID: 7782255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis.
    Giacometti A; Burzacchini F; Cirioni O; Barchiesi F; Dini M; Scalise G
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):885-9. PubMed ID: 10691200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.